Negative Pressure Wound Therapy Market to Grow at 6.6% CAGR by 2035, Driven by Rising Adoption of Home-Based Wound Care

The global Negative Pressure Wound Therapy (NPWT) Market was valued at USD 2.76 billion in 2025 and is projected to reach USD 5.46 billion by 2035, expanding at a CAGR of 6.6% during the forecast period 2026-2035. The market is gaining momentum as the rising prevalence of chronic wounds, diabetic foot ulcers, pressure ulcers, surgical wounds, and traumatic injuries increases demand for advanced wound-care solutions. Growing adoption of NPWT in hospitals and home-care settings, combined with advances in portable systems, single-use devices, automated therapy, and real-time wound monitoring, is further supporting market expansion.

The competitive opportunity is increasingly focused on portable, single-use, automated, and patient-centric wound-care technologies that can improve treatment convenience and support effective wound healing. Rising surgical procedures, the growing burden of diabetes-related wounds, and increasing demand for home-based wound management are encouraging healthcare providers to adopt advanced NPWT solutions. The market is therefore shifting toward compact devices, disposable systems, intelligent therapy management, remote monitoring, and home-based wound care, supporting sustained growth in the global negative pressure wound therapy market through 2035.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/negative-pressure-wound-therapy-market?sai-v

Recent Developments
June 2026: Convatec received FDA 510(k) clearance for its ConvaVAC NPWT System, designed for low- to moderately exuding chronic, traumatic, dehisced, graft, flap, and closed surgical wounds.

May 2026: Cork Medical received FDA clearance for a 500-mL disposable canister compatible with its Cork NPWT System and Nisus Touch pump, expanding fluid-management capacity for NPWT applications.

May 2026: Smith+Nephew received FDA clearance for the RENASYS EDGE NPWT System, reflecting continued development of portable and advanced NPWT platforms for wound management.

March 2026: Genadyne Biotechnologies received FDA 510(k) clearance for the Genadyne ASTRA NPWT System, adding another powered NPWT platform to the U.S. wound-care device landscape.

February 2026: Dynarex launched a new portable NPWT pump weighing 11.3 ounces and offering up to 72 hours of battery operation, highlighting continued industry emphasis on lightweight and portable wound-care solutions.

Key Players
3M Company | Advin Health Care | Medela AG | Gilero | Smith & Nephew plc | Cardinal Health Inc. | Convatec Inc. | Talley Group Ltd | Mölnlycke Health Care AB | DeRoyal | Others

Key Highlights
3M Company - Holds a 18.6% share, driven by its established negative pressure wound therapy systems, broad wound-care portfolio, strong clinical capabilities, and global distribution network.

Advin Health Care - Holds a 6.8% share, supported by its wound-care product portfolio and focus on innovative negative pressure wound therapy solutions.

Medela AG - Holds a 10.9% share, strengthened by its expertise in medical suction, wound therapy technologies, and established presence across hospital and home-care settings.

Gilero - Holds a 7.4% share, supported by its medical device engineering capabilities and development of advanced wound-care and negative pressure therapy technologies.

Smith & Nephew plc - Holds a 16.2% share, driven by its comprehensive advanced wound management portfolio, established NPWT solutions, and strong global healthcare presence.

Cardinal Health Inc. - Holds a 9.8% share, supported by its extensive medical product portfolio, healthcare distribution capabilities, and wound-care solutions.

Convatec Inc. - Holds a 10.5% share, strengthened by its advanced wound-care portfolio, innovative NPWT products, and global presence in chronic and complex wound management.

Talley Group Ltd - Holds a 5.6% share, supported by its expertise in pressure care, wound management technologies, and specialized medical equipment.

Mölnlycke Health Care AB - Holds a 8.9% share, driven by its advanced wound-care portfolio, surgical solutions, and focus on improving clinical outcomes for complex wounds.

DeRoyal - Holds a 3.7% share, supported by its broad medical product portfolio and focus on wound-care and negative pressure therapy solutions.

Others - Hold a combined 1.6% share, comprising emerging wound-care companies, specialized medical device manufacturers, regional suppliers, and technology providers contributing to the global NPWT market.

Get the Full Report Here: https://www.datamintelligence.com/buy-now-page?report=negative-pressure-wound-therapy-market?sai-v

Market Drivers
Rising prevalence of chronic wounds, diabetic foot ulcers, pressure ulcers, surgical wounds, and traumatic injuries, increasing demand for negative pressure wound therapy.

Growing adoption of NPWT for complex and hard-to-heal wounds due to its ability to support wound healing and fluid management.

Increasing incidence of diabetes and associated complications, particularly diabetic foot ulcers, driving demand for advanced wound-care solutions.

Rising number of surgical procedures and increasing need for effective postoperative wound management.

Growing preference for advanced wound-care technologies that can help reduce healing time, manage exudate, and support tissue regeneration.

Increasing healthcare expenditure and improving access to specialized wound-care services across developed and emerging markets.

Growing adoption of portable and single-use NPWT systems, supporting treatment in outpatient, home-care, and ambulatory settings.

Industry Developments
Development of portable and compact NPWT devices designed to improve patient mobility and enable treatment outside traditional hospital settings.

Increasing introduction of single-use NPWT systems offering simplified application, reduced maintenance requirements, and greater treatment convenience.

Strategic collaborations between medical device manufacturers, healthcare providers, and wound-care organizations to expand advanced wound-management solutions.

Increasing integration of advanced sensors, digital monitoring, and connected technologies into NPWT systems to improve treatment monitoring.

Expansion of NPWT applications across surgical wounds, diabetic foot ulcers, pressure ulcers, burns, and traumatic wounds.

Growing investment in advanced wound-care technologies focused on improving healing outcomes, reducing complications, and lowering overall treatment costs.

Regional Insights
North America - 41% share: "Driven by advanced healthcare infrastructure, high prevalence of chronic wounds and diabetes, strong adoption of advanced wound-care technologies, and increasing use of NPWT in hospitals and home-care settings."

Europe - 30% share: "Supported by established wound-care systems, rising adoption of advanced wound-management technologies, increasing surgical procedures, and growing demand for cost-effective wound treatment."

Asia Pacific - 23% share: "Fueled by the growing burden of diabetes and chronic wounds, expanding healthcare infrastructure, increasing healthcare expenditure, and improving access to advanced wound-care products."

Latin America - 4% share: "Supported by increasing prevalence of chronic wounds, improving healthcare access, and growing adoption of advanced wound-management technologies."

Middle East & Africa - 2% share: "Driven by rising diabetes-related wound complications, improving hospital infrastructure, increasing awareness of advanced wound care, and expanding access to NPWT systems."

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/negative-pressure-wound-therapy-market?sai-v

Key Segments
➥ By Device Type

Conventional NPWT Systems: Represents the dominant segment, driven by their established use in managing complex and chronic wounds, broad clinical acceptance, and increasing demand for advanced wound-healing solutions in hospital settings.

Single-use NPWT Devices: Represents the fastest-growing segment, fueled by their portability, ease of use, lower setup complexity, and increasing adoption in outpatient, ambulatory, and homecare wound management.

➥ By Dressings

Polysaccharides: Represents a significant segment, supported by their ability to manage wound exudate and maintain a favorable wound environment while supporting tissue repair.

Hydrocolloid Dressings: Represents an important segment, driven by their ability to provide moisture-balanced wound care and support healing across a range of wound types.

Gauze Dressings: Represents a significant segment, supported by their established clinical use, versatility, and compatibility with conventional NPWT systems for complex wound management.

Drapes: Represents a dominant segment, fueled by their essential role in creating an airtight seal around the wound and maintaining the negative-pressure environment required for effective therapy.

Others: Represents a growing segment, supported by continued development of advanced dressing materials and specialized wound-care products designed to improve patient comfort and treatment outcomes.

➥ By Wound Type

Diabetic Foot Ulcers: Represents a dominant segment, driven by the rising prevalence of diabetes, increasing incidence of chronic diabetic wounds, and growing adoption of NPWT for managing complex and non-healing ulcers.

Pressure Ulcers: Represents a significant segment, supported by the increasing prevalence of pressure injuries among elderly, immobile, and critically ill patients and the growing need for advanced wound management.

Venous Leg Ulcers: Represents an important segment, fueled by the chronic nature of venous ulcers and increasing demand for therapies that support wound closure and tissue regeneration.

Burns: Represents a significant segment, driven by the need for effective exudate management, infection control, and accelerated healing in complex and extensive burn wounds.

Surgical & Traumatic Wounds: Represents a major segment, supported by the increasing volume of surgical procedures and traumatic injuries requiring advanced wound closure and postoperative wound management.

Other Wounds: Represents a growing segment, fueled by expanding clinical applications of NPWT across complex, acute, and chronic wounds that require specialized treatment.

➥ By End-User

Hospital & Clinics: Represents the dominant segment, driven by the high volume of complex wounds treated in healthcare facilities, availability of specialized wound-care teams, and increasing adoption of advanced NPWT systems.

Homecare: Represents the fastest-growing segment, supported by the increasing shift toward home-based wound management, improved portability of NPWT devices, shorter hospital stays, and growing preference for convenient long-term care.

Others: Represents a growing segment, supported by increasing adoption of NPWT across ambulatory care centers, rehabilitation facilities, and other specialized healthcare settings.

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.